Infernia is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Winmark Pharmaceuticals (P) Limited. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Zinc, Astaxanthine,Coenzyme Q 10,L-Carnitine,Lycopene. This drug comes in the form of Capsule. The general packing available for this medicine consists of 10 Capsule and is priced at Rs 300 (arround $4.2 US Dollar)
The main active ingredients or salts in Infernia are :
L-Carnitine-500 mg
Coenzyme Q 10-100 mg
Zinc-7.5 mg
Lycopene-5000 mcg
Astaxanthine-1 mg
Zinc Indication (Prescribed for or used as):
For more details on Zinc, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Zinc..
Astaxanthine Indication (Prescribed for or used as):
For more details on Astaxanthine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Astaxanthine..
Coenzyme Q 10 Indication (Prescribed for or used as):
For more details on Coenzyme Q 10, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Coenzyme Q 10..
L-Carnitine Indication (Prescribed for or used as):
For more details on L-Carnitine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : L-Carnitine..
Lycopene Indication (Prescribed for or used as):
For more details on Lycopene, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Lycopene..
Infernia Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Infernia, which have same Fixed-Dose Combination of active substances or ingredients (i.e. L-Carnitine-500 mg Coenzyme Q 10-100 mg Zinc-7.5 mg Lycopene-5000 mcg Astaxanthine-1 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.